Patent Assignment
Reel/Frame 021018/0022
Assignment of Assignor's Interest
Recorded: 2008-05-30
Received: 2008-05-30
Pages: 8
Assignor
NOVO NORDISK A/S
Executed: 2007-12-17
Assignee
TRANSTECH PHARMA, INC.
4170 MEDENHALL OAKS PKWY, HIGH POINT, NC, 27265, UNITED STATES
Covered Properties
(46)
Novel Medicaments
Application:
11/917,823 →
11BETA-Hydroxysteroid Dehydrogenase Type 1 Active Spiro Compounds
Application:
11/665,103 →
Compounds, Their Preparation and Use
Application:
11/579,712 →
Novel Compounds, Their Preparation and Use
Application:
11/579,716 →
Novel Compounds, Their Preparation and Use
Application:
11/579,717 →
Phenoxy Acetic Acids as Ppar Delta Activators
Application:
11/917,811 →
Pharmaceutical use of substituted amides
Application:
12/006,765 →
Substituted Homopiperidine, Piperidine or Pyrrolidine Derivatives
Application:
11/962,455 →
Novel Compounds, Their Preparations And Use
Application:
11/579,303 →
New heteocyclic H3 antagonists
Application:
60/934,514 →
Pharmaceutical use of substituted amides
Application:
60/926,924 →
Novel compounds
Application:
60/923,251 →
Substituted Piperazines and Diazepanes
Application:
11/784,967 →
11Beta-HSD1 active compounds
Application:
60/920,433 →
Biocompatible Wound Dressing
Application:
11/657,887 →
Novel Compounds, Their Preparation and Use
Application:
11/439,827 →
Novel Piperazines
Application:
11/334,207 →
Combination Therapy Using an 11BETA-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders
Application:
11/254,125 →
Pharmaceutical use of substituted amides
Application:
11/265,794 →
Pharmaceutical Use of Fused 1,2,4-Triazoles
Application:
11/247,847 →
Pharmaceutical Use of Substituted Pyrazolo[1,5-A]Pyrimidines
Application:
11/254,118 →
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
Application:
11/246,814 →
11BETA-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
Application:
11/244,745 →
Substituted Hexahydropyrrolo[1,2-a]Pyrazines, Octahydropyrido[1,2-a]-Pyrazines and Decahydropyrazino[1,2-A]Azepines
Application:
11/115,564 →
Motor Start Relay and an Electric Compressor Using Same
Application:
10/919,091 →
Substituted Piperidines
Application:
10/891,553 →
Substituted Homopiperidine, Piperidine or Pyrrolidine Derivatives
Application:
10/735,963 →
Dimeric dicarboxylic acid derivatives, their preparation and use
Application:
10/734,368 →
Peroxisome Proliferator Acticvated Receptor-Active Arylene Acetic Acid Derivatives
Application:
10/693,161 →
Novel Compounds, Their Preparation and Use
Application:
10/654,699 →
Substituted Hexahydropyrrolo[1,2-a]Pyrazines, Octahydropyrido[1,2-a]-Pyrazines and Decahydropyrazino[1,2-A]Azepines
Application:
10/453,106 →
Combination Therapy Using a Dual Ppar-a/Ppar-Y Activator and a Glp-1 Derivative for the Treatment of Metabolic Syndrome and Related Diseases and Disorders
Application:
10/442,284 →
Novel Aryl- and Heteroarylpiperazines
Application:
10/383,310 →
Compounds, Their Preparation and Use
Application:
10/370,856 →
Amides of Aminoalkyl-Substituted Azetidines, Pyrrolidines, Piperidines and Azepanes
Application:
10/354,341 →
Novel Compounds, Their Preparation and Use
Application:
10/272,613 →
Novel Substituted Piperidines
Application:
10/267,620 →
Novel Aminoazetidine,-Pyrrolidine and -Piperidine Derivatives
Application:
10/242,968 →
Novel Compounds, Their Preparation and Use
Application:
10/217,595 →
Imidazole Compounds
Application:
10/201,865 →
Peroxisome Proliferator-Activated Receptor (Ppar) Active Vinyl Carboxylic Acid Derivatives
Application:
10/201,456 →
Substituted Piperazines and Diazepanes
Application:
10/185,861 →
Imidazole Compounds
Application:
09/810,237 →
Imidazo Heterocyclic Compounds
Application:
09/810,311 →
New Compounds, Their Preparation and Use
Application:
09/770,896 →
Alkynyl-Subsituted Propionic Acid Derivatives, Their Preparation and Use
Application:
09/771,217 →